20 June 2023: Original Paper
Survival Analysis of Transplant-Associated Thrombotic Microangiopathy Under Different Diagnostic Criteria and Efficacy of Plasma Exchange
Yifan Xu 12ABCDEF , Yan Wei 12BF , Lijun Wang 2BC , Ning Lu 2BD , Yongli Wu 2BD , Liping Dou 2AF , Daihong Liu 2AF , Meng Li 2ADEF* , Chunji Gao 2ADEFG*DOI: 10.12659/AOT.939890
Ann Transplant 2023; 28:e939890
Table 5 Risk stratification distribution of PE and non-PE groups.
| Criteria | Risk | Non-PE (n=8) | PE (n=11) | P value | |
|---|---|---|---|---|---|
| O-TMA | TMA index | Low | 6 (75.0%) | 5 (45.5%) | 0.52 |
| Intermediate | 2 (25.0%) | 4 (36.4%) | |||
| High | 0 (0.0%) | 2 (18.2%) | |||
| BATAP | Low | 3 (37.5%) | 2 (18.2%) | 0.700 | |
| Intermediate | 4 (50.0%) | 6 (54.4%) | |||
| High | 1 (12.5%) | 3 (27.3%) | |||
| Jodele TMA | TMA index | Low | 6 (66.7%) | 5 (38.5%) | 0.498 |
| Intermediate | 3 (33.3%) | 7 (53.8%) | |||
| High | 0 (0.0%) | 1 (7.7%) | |||
| BATAP | Low | 2 (22.2%) | 3 (23.1%) | 0.642 | |
| Intermediate | 6 (66.7%) | 6 (46.2%) | |||
| High | 1 (11.1%) | 4 (30.8%) | |||
| PE – plasma exchange. | |||||